Ziad brings more than two decades of experience working in the medical device industry as an executive and leader of clinical operations and regulatory affairs for emerging startups and high-growth businesses. He currently serves as President and CEO of Biomodex, a transformative digital healthcare company offering bio-realistic haptic simulators for patient-specific rehearsal and physician training. Prior to Biomodex, Ziad served as Vice President of Regulatory and Clinical Affairs at Juul Labs, which was acquired by Altria in 2018. Previously, he served as Vice President of Regulatory and Clinical Affairs for PQ Bypass, a pioneering Fogarty Innovation startup that was recently acquired by Endologix for more than $300 million. In 2013, Ziad served as Vice President of Regulatory, Clinical and Quality Affairs for Altura Medical before the endovascular repair device maker was acquired by Lombard Medical for $50.5 million. His diverse work experiences include senior positions at Bay Area Biotech, Auxogyn, and Avinger, Codman, Evalve, and Guidant. Ziad received both a BS and BA from McGill University and a J.D. from Rutgers University.